The United States’ Consumer Product Safety Commission (CPSC) administers the Poison Prevention Packaging Act of 1970 (PPPA) in order to protect children from the inadvertent ingestion of dangerous household products, including pharmaceuticals. The current test protocol for child-resistance (CR) and “senior friendliness” indicates that people with “overt or obvious disabilities” or people that cannot open a non-CR package be excluded from testing. Although people with disabilities are significant consumers of prescription drugs, the protocol excludes them. The exclusion of this group from government-directed testing unfairly punishes the elderly, who are more likely to be afflicted by disability than younger consumers. This is despite the fact that this portion of the test is meant to be a test of senior friendliness. Difficulties encountered when using packaging have also been documented to impact patient compliance, which is recognized as a significant problem of the healthcare system in the US. This research hypothesizes that by using an interdisciplinary team and applying the concepts of universal design to CR packaging, users with a wider range of abilities can be accommodated. Inclusionary designs will improve products and benefit all users, not just those with disabilities. Background and significance Drug packages protect and deliver prescription and over the counter drugs (OTC’s), as well as communicate necessary warnings and directions to people so that the pharmaceuticals held within can be used to enhance health. This project addresses two major issues of concern in public health that are related to packaging design: patient compliance and child safety.
This Research Database has been developed by HCPC Europe to create an overview of the available research in the field of patient-friendly and adherence packaging. The database is for all members of HCPC Europe. Members can register as a user to get access to the database. Is your organisation not a member yet? Then please register your organisation as a member or contact our Executive Director Ger Standhardt for more information.